[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"type-i-complex-regional-pain-syndrome\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:type-i-complex-regional-pain-syndrome":26},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":4,"eligibilityCriteria":15,"healthyVolunteers":11,"sex":16,"minAge":17,"maxAge":4,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":27,"overallStatus":31,"whyStopped":4,"lastUpdateSubmitDate":32,"lastUpdatePostDateStruct":33,"startDateStruct":36,"completionDateStruct":38,"leadSponsor":40,"locationsCount":5},"100443310","non-invasive-neurostimulation-technology-for-the-treatment-of-type-i-complex-regional-pain-syndrome-crps-i-100443310",false,"NCT05052736","Non Invasive Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)","Effectiveness and Safety of NXsignal Applied Surface Neurostimulation Technology for the Treatment of Type I Complex Regional Pain Syndrome (CRPS I)","Inclusion Criteria:\n\n* Meet the Budapest criteria for the clinical diagnosis of CRPS type I.\n* Age between 18 and 65.\n* Period between 0 and 6 months after the onset of the clinical picture.\n* Have signed the informed consent of their own free will.\n\nExclusion Criteria:\n\n* Have a diagnosis of CRPS type II.\n* Present type I CRPS in more than one limb.\n* Patients who have suffered a recurrence of CRPS type I.\n* Pregnancy or plans for it during the study.\n* Previous sympathectomy in the affected limb.","ALL","18 Years",{"count":19,"type":20},42,"ESTIMATED","INTERVENTIONAL",[23],"NA","Complex Regional Pain Syndrome (CRPS) \u002F Complex Regional Pain Syndrome (CRPS) is a chronic neurological disorder that affects the extremities and is characterized by disabling pain, swelling, vasomotor instability, sudomotor abnormality, and impaired motor function; the duration and clinical magnitude is greater than expected, being divided into three stages of progression over time: Stage I: acute (0-3 months); Stage II: dystrophic (3-9 months); Stage 3: atrophic (9-18 months).\n\nThe purpose of this study is to investigate the effect on complex pain syndrome using a conventional care protocol plus the application of non-invasive neuromodulation during compared to the effect of the same protocol plus placebo.",[26],"Type I Complex Regional Pain Syndrome",[28,29,30],"physical therapy modality","Electric Stimulation Therapy","pain","RECRUITING","2025-08-21",{"date":34,"type":35},"2025-08-28","ACTUAL",{"date":37,"type":35},"2022-03-28",{"date":39,"type":20},"2026-12-27",{"name":41,"class":42},"University of Las Palmas de Gran Canaria","OTHER"]